Results 171 to 180 of about 34,084,722 (297)

A new synthetic toll-like receptor 1/2 ligand is an efficient adjuvant for peptide vaccination in a human volunteer. [PDF]

J Immunother Cancer, 2019
Rammensee HG, Wiesmüller KH, Chandran PA, Zelba H, Rusch E, Gouttefangeas C, Kowalewski DJ, Di Marco M, Haen SP, Walz JS, Gloria YC, Bödder J, Schertel JM, Tunger A, Müller L, Kießler M, Wehner R, Schmitz M, Jakobi M, Schneiderhan-Marra N, Klein R, Laske K, Artzner K, Backert L, Schuster H, Schwenck J, Weber ANR, Pichler BJ, Kneilling M, la Fougère C, Forchhammer S, Metzler G, Bauer J, Weide B, Schippert W, Stevanović S, Löffler MW.   +36 more
europepmc   +1 more source

Metabolic Memory in Cardiovascular Disease: Encoding, Propagation, and Therapeutic Targeting

Advanced Science, EarlyView.
Cardiovascular risk often persists after metabolic abnormalities are corrected. This conceptual Review frames such persistence as metabolic memory, encoded through a narrowing therapeutic window from reversible marks to irreversible damage, with continuous input from peripheral organs.
Cheng Cheng, Minghui Tang, Zhaobo Zhang, Ruoyi Qu, Jianfei Pei, Tian Liu, Siyao Qu, Shilong You, Shenshen Cui, Wenke Wang, Rui Zhao, Yingxian Sun, Naijin Zhang   +12 more
wiley   +1 more source

Toll-like receptor 1 polymorphism is associated with impaired immune tolerance, dysregulated inflammatory responses to <i>Borrelia burgdorferi</i>, and heightened risk of post-infectious Lyme arthritis. [PDF]

Front Immunol
Williams MA, Hernandez SA, Arvikar SL, Sulka KB, Strle F, Wells CC, Petnicki-Ocwieja T, Steere AC, Strle K.   +8 more
europepmc   +1 more source

Toll-Like Receptor-1 Single-Nucleotide Polymorphism 1805T/G Is Associated With Predisposition to Multibacillary Tuberculosis. [PDF]

Front Immunol, 2018
Barletta-Naveca RH, Naveca FG, de Almeida VA, Porto JIR, da Silva GAV, Ogusku MM, Sadahiro A, Ramasawmy R, Boechat AL.   +8 more
europepmc   +1 more source

Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer‐Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy

Advanced Science, EarlyView.
A Transformer‐based AI framework, DLINP, screens millions of compounds to identify Co68, a cobalt‐pincer organometallic complex that biases TLR4‐MD2 signaling toward antitumor interferon activation while suppressing inflammatory toxicity through an early TLR4‐SYK‐STAT1 axis.
Xuefei Guo, Yang Zhao, Xianle Rong, Xingyu Chen, Xiao Wang, Tianyi Liu, Yunfei Xie, Yushu Zou, Pingsen Zhao, Qiang Liu, Fuping You   +10 more
wiley   +1 more source

Dehydrometabolites of siphonaxanthin, a carotenoid from green algae, suppress toll-like receptor 1/2-induced inflammatory response more strongly than siphonaxanthin. [PDF]

J Biol Chem
Manabe Y, Nitta T, Ichihara M, Maoka T, Sugawara T.   +4 more
europepmc   +1 more source

Streptococcal Mannose Phosphotransferase System Component IID Is a Novel RANK‐Binding Osteoclastogenic Factor

Advanced Science, EarlyView.
Streptococcal mannose phosphotransferase system component IID (Man‐PTSIID) is identified as a novel RANK‐binding osteoclastogenic factor. By directly binding to RANK and activating NF‐κB independently of TLR2, Man‐PTSIID drives osteoclastogenesis and inflammatory bone destruction, uncovering an unexpected microbial mechanism underlying streptococcal ...
Chaeyeon Park, Yeongkag Kwon, Yeonjin Lim, Jeong Woo Park, Hyun Jung Ji, Dongwook Lee, Jueun Lee, Sung‐Ho Yun, Sungho Jeong, Ho Seong Seo, Kun Cho, Cheol‐Heui Yun, Ok‐Jin Park, Seung Hyun Han   +13 more
wiley   +1 more source

Cellular expression of A20 and ABIN-3 in response to Toll-like receptor-4 stimulation

, 2009
Although Toll-like receptor (TLR)-induced expression of several proinflammatory genes is required to provoke an efficient immune response, excessive or prolonged activation of TLR signaling can contribute to the development of septic shock and several ...
Carpentier, IsabelleWE148010011200050009-0009-9450-5950F51FD2CE-F0ED-11E1-A9DE-61C894A0A6B4, McCoy, Claireeditor, Beyaert, RudiWE148010006306580000-0002-5704-582XF43C694E-F0ED-11E1-A9DE-61C894A0A6B4, Verhelst, KellyUGent0020002064828010020958639721282055610000-0001-8485-3833F81EB9B8-F0ED-11E1-A9DE-61C894A0A6B4, Verstrepen, LynnUGent0019983378208010016653269771606299260000-0003-1094-8754F687A092-F0ED-11E1-A9DE-61C894A0A6B4, O'Neill, Lukeeditor, Coornaert, Beatrice8010017198869231E418-B25E-11E6-B104-2D2FD0AF0289   +6 more
core  

Toll-like receptor 1/2 activation reduces immunoglobulin free light chain production by multiple myeloma cells in the context of bone marrow stromal cells and fibronectin. [PDF]

PLoS One
Abdi J, Redegeld F.
europepmc   +1 more source

Toll-like Receptor 1/2 Agonist Pam3CSK4 Suppresses Lipopolysaccharide-driven IgG1 Production while Enhancing IgG2a Production by B Cells. [PDF]

Immune Netw, 2018
Lee SH, Park SR.
europepmc   +1 more source